Produção Nacional
Revisado por pares
Detection of SARS‐CoV‐2 in a case of DRESS by sulfasalazine: could there be a relationship with clinical importance?
2020; Wiley; Volume: 60; Issue: 1 Linguagem: Inglês
10.1111/ijd.15316
ISSN1365-4632
AutoresSindy Natália Balconi, Natane Tenedini Lopes, Laura Luzzatto, Renan Rangel Bonamigo,
Tópico(s)Autoimmune and Inflammatory Disorders
ResumoInternational Journal of DermatologyVolume 60, Issue 1 p. 125-126 Correspondence Detection of SARS-CoV-2 in a case of DRESS by sulfasalazine: could there be a relationship with clinical importance? Sindy N. Balconi MD, Corresponding Author Sindy N. Balconi MD [email protected] orcid.org/0000-0002-6369-5474 Dermatology Service of Santa Casa de Misericórdia de Porto Alegre (ISCMPA, UFCSPA), Porto Alegre, RS, BrazilSearch for more papers by this authorNatane T. Lopes MD, Natane T. Lopes MD Dermatology Service of Ambulatório de Dermatologia Sanitária (ADS), Porto Alegre, RS, BrazilSearch for more papers by this authorLaura Luzzatto MD, Laura Luzzatto MD Dermatology Service of Santa Casa de Misericórdia de Porto Alegre (ISCMPA, UFCSPA), Porto Alegre, RS, BrazilSearch for more papers by this authorRenan R. Bonamigo MD, PhD, Renan R. Bonamigo MD, PhD Dermatology Service of Santa Casa de Misericórdia de Porto Alegre (ISCMPA, UFCSPA), Porto Alegre, RS, Brazil Dermatology Service of Ambulatório de Dermatologia Sanitária (ADS), Porto Alegre, RS, Brazil Medical School of Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, BrazilSearch for more papers by this author Sindy N. Balconi MD, Corresponding Author Sindy N. Balconi MD [email protected] orcid.org/0000-0002-6369-5474 Dermatology Service of Santa Casa de Misericórdia de Porto Alegre (ISCMPA, UFCSPA), Porto Alegre, RS, BrazilSearch for more papers by this authorNatane T. Lopes MD, Natane T. Lopes MD Dermatology Service of Ambulatório de Dermatologia Sanitária (ADS), Porto Alegre, RS, BrazilSearch for more papers by this authorLaura Luzzatto MD, Laura Luzzatto MD Dermatology Service of Santa Casa de Misericórdia de Porto Alegre (ISCMPA, UFCSPA), Porto Alegre, RS, BrazilSearch for more papers by this authorRenan R. Bonamigo MD, PhD, Renan R. Bonamigo MD, PhD Dermatology Service of Santa Casa de Misericórdia de Porto Alegre (ISCMPA, UFCSPA), Porto Alegre, RS, Brazil Dermatology Service of Ambulatório de Dermatologia Sanitária (ADS), Porto Alegre, RS, Brazil Medical School of Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, RS, BrazilSearch for more papers by this author First published: 24 November 2020 https://doi.org/10.1111/ijd.15316Citations: 8 Conflict of interest: None. Funding source: None. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Watanabe H. Recent advances in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. J Immunol Res 2018; 2018: 5163129. 10.1155/2018/5163129 PubMedWeb of Science®Google Scholar 2Cho YT, Yang CW, Chu CY. Drug reaction with eosinophilia and systemic symptoms (DRESS): an interplay among drugs, viruses, and immune system. Int J Mol Sci 2017; 18: 1243. 10.3390/ijms18061243 CASPubMedWeb of Science®Google Scholar 3Marzano AV, Cassano N, Genovese G, et al. Cutaneous manifestations in patients with COVID-19: a preliminary review of an emerging issue. Br J Dermatol 2020; 183: 431–442. 10.1111/bjd.19264 CASPubMedWeb of Science®Google Scholar 4Roujeau JC, Dupin N. Virus Reactivation in drug reaction with eosinophilia and systemic symptoms (Dress) results from a strong drug-specific immune response. J Allergy Clin Immunol Pract 2017; 5: 811–812. 10.1016/j.jaip.2016.11.027 PubMedWeb of Science®Google Scholar 5Jamilloux Y, Henry T, Belot A, et al. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions. Autoimmun Rev 2020; 19: 102567. 10.1016/j.autrev.2020.102567 CASPubMedWeb of Science®Google Scholar Citing Literature Volume60, Issue1January 2021Pages 125-126 ReferencesRelatedInformation
Referência(s)